Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant neoplasm of the nasopharyngeal epithelium. Concurrent chemoradiotherapy has been established as a standard treatment for locoregional NPC, and cisplatin is a common agent in NPC treatment. Cetuximab is a monoclonal antibody against epidermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Liu, Dianjun, Wei, Deyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433239/
https://www.ncbi.nlm.nih.gov/pubmed/36060662
http://dx.doi.org/10.1155/2022/5145549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433239/
https://www.ncbi.nlm.nih.gov/pubmed/36060662
http://dx.doi.org/10.1155/2022/5145549

Ejemplares similares